Home > Qtrly Results > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Quarterly Results Analysis [Dec2023]

BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Quarterly Results

Standalone Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
UnAudited
Dec2022
UnAudited
Sep2022
UnAudited
Jun2022
UnAudited
Mar2022
UnAudited
Revenues ₹28 Cr ₹41 Cr ₹42 Cr ₹42 Cr ₹34 Cr ₹22 Cr ₹17 Cr ₹15 Cr
Expenses ₹31 Cr ₹37 Cr ₹36 Cr ₹35 Cr ₹31 Cr ₹19 Cr ₹15 Cr ₹15 Cr
Operating Income ₹-2 Cr ₹4 Cr ₹6 Cr ₹8 Cr ₹3 Cr ₹3 Cr ₹2 Cr ₹0 Cr
Other Income ₹1 Cr ₹0 Cr ₹2 Cr ₹0 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Interest ₹1 Cr ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹2 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹-3 Cr ₹2 Cr ₹6 Cr ₹6 Cr ₹3 Cr ₹2 Cr ₹1 Cr ₹-1 Cr
Profit After Tax ₹-3 Cr ₹2 Cr ₹6 Cr ₹5 Cr ₹3 Cr ₹2 Cr ₹1 Cr ₹-1 Cr
EPS ₹-1.24 ₹1.05 ₹2.68 ₹2.27 ₹1.27 ₹0.68 ₹0.58 ₹-0.40
Industry Peers & Returns1W1M1Y
BAFNA PHARMACEUTICALS -1% -11.8% -18%
SUN PHARMACEUTICAL INDUSTRIES 3% 2.3% 68.2%
CIPLA 2.5% 0.4% 71.7%
DR REDDYS LABORATORIES -0.2% -4.9% 40.3%
ZYDUS LIFESCIENCES 5% 10.4% 109.1%
DIVIS LABORATORIES -1.6% -7% 23.8%
MANKIND PHARMA NA NA NA
TORRENT PHARMACEUTICALS 2.9% -2.2% 69%
LUPIN 2.8% 0% 147.8%

BAFNA PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

-30.08 %

Y-o-Y

-16.88 %

Quarters Revenues % Change
Dec2023 ₹28 Cr
-30.08
Sep2023 ₹41 Cr
-3.03
Jun2023 ₹42 Cr
-0.70
Mar2023 ₹42 Cr
23.46
Dec2022 ₹34 Cr
55.81
Sep2022 ₹22 Cr
29.74
Jun2022 ₹17 Cr
12.98
Mar2022 ₹15 Cr -

BAFNA PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Profit % Change
Dec2023 ₹-2 Cr
Negative
Sep2023 ₹4 Cr
-36.39
Jun2023 ₹6 Cr
-17.39
Mar2023 ₹8 Cr
150.49
Dec2022 ₹3 Cr
19.67
Sep2022 ₹3 Cr
53.22
Jun2022 ₹2 Cr
Positive
Mar2022 ₹0 Cr -
Operating Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Margin% % Change
Dec2023 -7.3%
Negative
Sep2023 9.84%
-34.44
Jun2023 15.01%
-16.80
Mar2023 18.04%
102.92
Dec2022 8.89%
-23.23
Sep2022 11.58%
18.16
Jun2022 9.8%
Positive
Mar2022 -2.54% -

BAFNA PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Dec2023 ₹-3 Cr
Negative
Sep2023 ₹2 Cr
-60.88
Jun2023 ₹6 Cr
18.23
Mar2023 ₹5 Cr
79.33
Dec2022 ₹3 Cr
86.02
Sep2022 ₹2 Cr
18.30
Jun2022 ₹1 Cr
Positive
Mar2022 ₹-1 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Dec2023 -10.35 %
Negative
Sep2023 6.11 %
-59.64
Jun2023 15.14 %
19.12
Mar2023 12.71 %
45.26
Dec2022 8.75 %
19.37
Sep2022 7.33 %
-8.83
Jun2022 8.04 %
Positive
Mar2022 -6.34 % -

BAFNA PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Dec2023 ₹-1.24
Negative
Sep2023 ₹1.05
-60.82
Jun2023 ₹2.68
18.06
Mar2023 ₹2.27
78.74
Dec2022 ₹1.27
86.76
Sep2022 ₹0.68
17.24
Jun2022 ₹0.58
Positive
Mar2022 ₹-0.4 -

You may also like the below Video Courses